Related references
Note: Only part of the references are listed.Screening for primary aldosteronism in the hypertensive obstructive sleep apnea population is cost-saving
Kathryn Chomsky-Higgins Menut et al.
SURGERY (2022)
Aldosterone Inhibits In Vitro Myogenesis by Increasing Intracellular Oxidative Stress via Mineralocorticoid Receptor
Jin Young Lee et al.
ENDOCRINOLOGY AND METABOLISM (2021)
Nocturnal hypoxemia severity influences the effect of CPAP therapy on renal renin-angiotensin-aldosterone system activity in humans with obstructive sleep apnea
David D. M. Nicholl et al.
SLEEP (2021)
Association between autonomic function and obstructive sleep apnea: A systematic review
Hasthi U. Dissanayake et al.
SLEEP MEDICINE REVIEWS (2021)
Primary aldosteronism is highly prevalent in patients with hypertension and moderate to severe obstructive sleep apnea
Piotr Dobrowolski et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2021)
Intermittent Hypoxia Upregulates the Renin and Cd38 mRNAs in Renin-Producing Cells via the Downregulation of miR-203
Yoshinori Takeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Efficacy of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH): Systematic review and meta-analysis
Gonzalo Labarca et al.
SLEEP MEDICINE REVIEWS (2021)
Prevalence, diagnosis and outcomes of treatment for primary aldosteronism
Yuhong Yang et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Obstructive Sleep Apnea and Arterial Hypertension: Implications of Treatment Adherence
Tomas Posadas et al.
CURRENT HYPERTENSION REPORTS (2020)
Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis
Martino F. Pengo et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Mineralocorticoid Receptors in Metabolic Syndrome: From Physiology to Disease
Alessandra Feraco et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
Sleep apnoea and endothelial dysfunction: An individual patient data meta-analysis
Vanessa Bironneau et al.
SLEEP MEDICINE REVIEWS (2020)
Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy
Jeovanna Lowe et al.
ESC HEART FAILURE (2020)
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism
Gian Paolo Rossi et al.
INTERNATIONAL JOURNAL CARDIOLOGY HYPERTENSION (2020)
The Differential Effect of Excess Aldosterone on Skeletal Muscle Mass by Sex
Mi Kyung Kwak et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Clinical characteristics of snoring patients with primary aldosteronism and obstructive sleep apnea–hypopnea syndrome
Mingyan Li et al.
JOURNAL OF HUMAN HYPERTENSION (2019)
Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea
Elizabeth Wang et al.
JOURNAL OF SURGICAL RESEARCH (2019)
The Effects of Eplerenone on the Circadian Blood Pressure Pattern and Left Ventricular Hypertrophy in Patients with Obstructive Sleep Apnea and Resistant Hypertension-A Randomized, Controlled Trial
Beata Krasinska et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives
Brian C. Ruhle et al.
SURGERY (2019)
Managing comorbid cardiovascular disease and sleep apnea with pharmacotherapy
Jacek Wolf et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Continuous Positive Airway Pressure Reduces Night-Time Blood Pressure and Heart Rate in Patients With Obstructive Sleep Apnea and Resistant Hypertension: The RHOOSAS Randomized Controlled Trial
Marie Joyeux-Faure et al.
FRONTIERS IN NEUROLOGY (2018)
Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea
M. J. Wolley et al.
JOURNAL OF HUMAN HYPERTENSION (2017)
Risk of obstructive sleep apnea among patients with Cushing's syndrome: a nationwide longitudinal study
Ling-Uei Wang et al.
SLEEP MEDICINE (2017)
Association of aldosterone excess and apnea-hypopnea index in patients with resistant hypertension
Xiao Ke et al.
SCIENTIFIC REPORTS (2017)
Detection of Secondary Causes and Coexisting Diseases in Hypertensive Patients: OSA and PA Are the Common Causes Associated with Hypertension
Lei Wang et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Wiebke Arlt et al.
JCI INSIGHT (2017)
Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea
Lirui Yang et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2016)
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
John W. Funder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Trends in CPAP adherence over twenty years of data collection: a flattened curve
Brian W. Rotenberg et al.
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2016)
Effect of eplerenone on the severity of obstructive sleep apnea and arterial stiffness in patients with resistant arterial hypertension
Beata Krasinska et al.
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE (2016)
Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target
Jessica A. Chadwick et al.
FASEB JOURNAL (2015)
Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea Blood Pressure Response to Continuous Positive Airway Pressure Treatment
Manuel Sanchez-de-la-Torre et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Sleep apnea syndrome in endocrine clinics
F. Ceccato et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Evaluation of Continuous Positive Airway Pressure Therapy on Renin-Angiotensin System Activity in Obstructive Sleep Apnea
David D. M. Nicholl et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Effects of OSA Treatment on BP in Patients With Resistant Hypertension A Randomized Trial
Rodrigo P. Pedrosa et al.
CHEST (2013)
Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?
Louise A. Burton et al.
CLINICAL ENDOCRINOLOGY (2011)
Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population
John J. Sim et al.
JOURNAL OF HYPERTENSION (2011)
Relationship Between Overnight Rostral Fluid Shift and Obstructive Sleep Apnea in Drug-Resistant Hypertension
Oded Friedman et al.
HYPERTENSION (2010)
Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report
K. Gaddam et al.
JOURNAL OF HUMAN HYPERTENSION (2010)
Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism
A. Di Murro et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2010)
Pathophysiology of Sleep Apnea
Jerome A. Dempsey et al.
PHYSIOLOGICAL REVIEWS (2010)
A novel adipokine CTRP1 stimulates aldosterone production
Jun Ho Jeon et al.
FASEB JOURNAL (2008)
Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo
JG Burniston et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea
DA Calhoun et al.
CHEST (2004)
Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea
N Meston et al.
JOURNAL OF INTERNAL MEDICINE (2003)
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension
AG Logan et al.
JOURNAL OF HYPERTENSION (2001)